<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: therapeutic strategies</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Estrogen fuels autoimmune liver damage</title>
   	 <description>A life-threatening condition that often requires transplantation and accounts for half of all acute liver failures, autoimmune hepatitis is often precipitated by certain anesthetics and antibiotics. Researchers say these drugs contain tiny molecules called haptens that ever so slightly change normal liver proteins, causing the body to mistake its own liver cells for foreign invaders and to attack them. The phenomenon disproportionately occurs in women, even when they take the same drugs at the same doses as men.</description>
	  <link>http://medicalxpress.com/news/2013-04-estrogen-fuels-autoimmune-liver.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 30 Apr 2013 13:48:32 EST</pubDate>
	 <guid isPermaLink="false">news286548506</guid>
	 
</item>
<item>
     <title>Gene controls three different diseases</title>
   	 <description>An international research consortium led by the Universitat Autònoma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered.</description>
	  <link>http://medicalxpress.com/news/2013-04-gene-diseases.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 25 Apr 2013 12:00:15 EST</pubDate>
	 <guid isPermaLink="false">news286108969</guid>
	 
</item>
<item>
     <title>Study shines light on how stress circuits learn</title>
   	 <description>Researchers at the University of Calgary's Hotchkiss Brain Institute have discovered that stress circuits in the brain undergo profound learning early in life. Using a number of cutting edge approaches, including optogenetics, Jaideep Bains, PhD, and colleagues have shown stress circuits are capable of self-tuning following a single stress. These findings demonstrate that the brain uses stress experience during early life to prepare and optimize for subsequent challenges.</description>
	  <link>http://medicalxpress.com/news/2013-04-stress-circuits.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Sun, 07 Apr 2013 13:00:02 EST</pubDate>
	 <guid isPermaLink="false">news284557977</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/brain.gif" width="90" height="96" />
</item>
<item>
     <title>Researchers identify a potential new therapeutic target for E. coli infections</title>
   	 <description>(Medical Xpress)—A new study by researchers at the Center for Modeling Immunity to Enteric Pathogens at Virginia Bioinformatics Institute provides novel insight into how an emerging strain of the diarrhea-causing bacteria E. coli interacts with its host.</description>
	  <link>http://medicalxpress.com/news/2013-03-potential-therapeutic-coli-infections.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 28 Mar 2013 08:40:03 EST</pubDate>
	 <guid isPermaLink="false">news283677820</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/7-6-5-4-3-2-1-researchersi.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists discover that DNA damage occurs as part of normal brain activity</title>
   	 <description>Scientists at the Gladstone Institutes have discovered that a certain type of DNA damage long thought to be particularly detrimental to brain cells can actually be part of a regular, non-harmful process. The team further found that disruptions to this process occur in mouse models of Alzheimer's disease—and identified two therapeutic strategies that reduce these disruptions.</description>
	  <link>http://medicalxpress.com/news/2013-03-scientists-dna-brain.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Sun, 24 Mar 2013 14:10:01 EST</pubDate>
	 <guid isPermaLink="false">news283335265</guid>
	 
</item>
<item>
     <title>New clues to causes of peripheral nerve damage</title>
   	 <description>(Medical Xpress)—Anyone whose hand or foot has &quot;fallen asleep&quot; has an idea of the numbness and tingling often experienced by people with peripheral nerve damage. The condition also can cause a range of other symptoms, including unrelenting pain, stinging, burning, itching and sensitivity to touch.</description>
	  <link>http://medicalxpress.com/news/2013-03-clues-peripheral-nerve.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 07 Mar 2013 07:07:50 EST</pubDate>
	 <guid isPermaLink="false">news281862461</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/newcluestoca.jpg" width="90" height="92" />
</item>
<item>
     <title>A step towards better understanding of pancreatic cancer</title>
   	 <description>(Medical Xpress)—An international team of scientists has observed that the well-studied protein Sirtuin-1, known for helping cells live longer, also appears to play an important role in pancreatic cancer.</description>
	  <link>http://medicalxpress.com/news/2013-02-pancreatic-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 05 Feb 2013 08:44:09 EST</pubDate>
	 <guid isPermaLink="false">news279276224</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/3-image.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists shed light on mystery surrounding hepatitis B virus: Discovery is decades in the making</title>
   	 <description>(Medical Xpress)—Scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, and the University of Oxford, U.K., have shed light on a long-standing enigma about the structure of a protein related to the Hepatitis B virus. Their findings, reported in Structure, could lead to new therapeutic strategies for chronic liver disease.</description>
	  <link>http://medicalxpress.com/news/2013-01-scientists-mystery-hepatitis-virus-discovery.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 09 Jan 2013 06:29:17 EST</pubDate>
	 <guid isPermaLink="false">news276935350</guid>
	 
</item>
<item>
     <title>Indigenous Australians vulnerable to lupus</title>
   	 <description>(Medical Xpress)—A new study is currently exploring why Indigenous Australians (IA) suffer more frequently and severely from lupus than non-Indigenous Australians (NIA).</description>
	  <link>http://medicalxpress.com/news/2012-12-indigenous-australians-vulnerable-lupus.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 14 Dec 2012 06:47:44 EST</pubDate>
	 <guid isPermaLink="false">news274690055</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/indigenousau.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers say effective immunotherapy for melanoma hinges on blocking suppressive factors</title>
   	 <description>(Medical Xpress)—Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them. Blocking myeloid-derived suppressor cells and regulatory T-cell reconstitution improved adoptive T-cell therapy, an immunotherapy designed to suppress tumor activity.</description>
	  <link>http://medicalxpress.com/news/2012-12-effective-immunotherapy-melanoma-hinges-blocking.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 11 Dec 2012 03:48:04 EST</pubDate>
	 <guid isPermaLink="false">news274420077</guid>
	 
</item>
<item>
     <title>A study of fruit fly genes reveals how molecules cooperate to induce tumor formation</title>
   	 <description>Cancer biologists have known for decades that even the most potent cancer-causing genes do not act alone. Yet, identifying which combinations of genetic changes can cause a tumor to form and disease to progress remains a challenge. &quot;The hope is that by understanding these [combinations], it will be possible to design therapeutic strategies tailored to the genetic changes in different cancers,&quot; says Stephen Cohen of the A*STAR Institute of Molecular and Cell Biology (IMCB) and the National University of Singapore.</description>
	  <link>http://medicalxpress.com/news/2012-12-fruit-genes-reveals-molecules-cooperate.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 05 Dec 2012 08:10:41 EST</pubDate>
	 <guid isPermaLink="false">news273917424</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-cancerbiolog.jpg" width="90" height="90" />
</item>
<item>
     <title>Gene linked to respiratory distress in babies</title>
   	 <description>(Medical Xpress)—Some infants are more susceptible to potentially life-threatening breathing problems after birth, and rare, inherited DNA differences may explain why, according to research at Washington University School of Medicine in St. Louis.</description>
	  <link>http://medicalxpress.com/news/2012-11-gene-linked-respiratory-distress-babies.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Tue, 27 Nov 2012 12:17:55 EST</pubDate>
	 <guid isPermaLink="false">news273241063</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/2-genelinkedto.jpg" width="90" height="90" />
</item>
<item>
     <title>CDC and NIH survey provides first report of state-level COPD prevalence</title>
   	 <description>The age-adjusted prevalence of chronic obstructive pulmonary disease (COPD) varies considerably within the United States, from less than 4 percent of the population in Washington and Minnesota to more than 9 percent in Alabama and Kentucky. These state-level rates are among the COPD data available for the first time as part of the newly released 2011 Behavioral Risk Factor Surveillance System (BRFSS) survey.</description>
	  <link>http://medicalxpress.com/news/2012-11-cdc-nih-survey-state-level-copd.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 21 Nov 2012 13:19:47 EST</pubDate>
	 <guid isPermaLink="false">news272726363</guid>
	 
</item>
<item>
     <title>Are we closer to understanding the cause of deadly sepsis?</title>
   	 <description>Following an infection, dysregulation of the immune system can result in a systemic inflammatory response and an often fatal condition called severe sepsis or septic shock. Sepsis is not uncommon, yet its cause and underlying immune dysfunction remain poorly understood. Regulatory T cells (Tregs), a component of the immune system, now appear to have an important role in suppressing the immune response in advance of sepsis, and understanding this role may lead to new therapeutic strategies for improving patient outcomes, as described in a review article in Journal of Interferon &amp; Cytokine Research.</description>
	  <link>http://medicalxpress.com/news/2012-11-closer-deadly-sepsis.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 16 Nov 2012 12:56:11 EST</pubDate>
	 <guid isPermaLink="false">news272292918</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/areweclosert.jpg" width="90" height="90" />
</item>
<item>
     <title>Identification of mutations common to half of all liver cancers provides leads for new therapeutics</title>
   	 <description>Liver cancer is the sixth most common cancer worldwide and the third leading cause of cancer-associated deaths. Yet even for such a frequent and deadly disease, the pathogenesis of this cancer remains obscure. Now, a team of scientists in Japan has shown that genes involved in regulating how tightly DNA is wound into chromosomes are commonly mutated in liver tumors. The finding points to potential new and much-needed therapeutic strategies.</description>
	  <link>http://medicalxpress.com/news/2012-11-identification-mutations-common-liver-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 16 Nov 2012 07:14:42 EST</pubDate>
	 <guid isPermaLink="false">news272272473</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/5-identificati.jpg" width="90" height="90" />
</item>
<item>
     <title>Measuring metabolism can predict Alzheimer's progress with 90 percent accuracy</title>
   	 <description>A new study from Tel Aviv University suggests that early clues about the progression of the disease can be found in the metabolism of the brain, making it possible to detect and diagnose Alzheimer's at an early stage with a simple blood test.</description>
	  <link>http://medicalxpress.com/news/2012-11-metabolism-alzheimer-percent-accuracy.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Wed, 07 Nov 2012 14:46:53 EST</pubDate>
	 <guid isPermaLink="false">news271521985</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/measuringmet.jpg" width="90" height="90" />
</item>
<item>
     <title>Proteins in DNA damage response network targeted for new therapies, researchers say</title>
   	 <description>(Medical Xpress)—Researchers at Moffitt Cancer Center and colleagues at the University of South Florida; Duke University; Johns Hopkins University; the Brazilian National Cancer Institute; and the Rio de Janeiro Federal Institute of Education, Science and Technology have discovered that an intricate system to repair DNA damage called the &quot;DNA damage response&quot; (DDR) contains previously unknown components, including proteins that could be targeted as sensitizers for chemotherapy. Some of these targets may already have drugs available that have unrecognized uses in cancer therapy, said the researchers.</description>
	  <link>http://medicalxpress.com/news/2012-10-proteins-dna-response-network-therapies.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 16 Oct 2012 04:13:09 EST</pubDate>
	 <guid isPermaLink="false">news269579571</guid>
	 
</item>
<item>
     <title>Breakthrough in understanding lung cancer vulnerabilities points the way to new targeted therapy</title>
   	 <description>More effective treatments for one of the deadliest forms of cancer are one step closer thanks to groundbreaking research from an international collaborative study.</description>
	  <link>http://medicalxpress.com/news/2012-10-breakthrough-lung-cancer-vulnerabilities-therapy.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 01 Oct 2012 15:00:37 EST</pubDate>
	 <guid isPermaLink="false">news268315602</guid>
	 
</item>
<item>
     <title>Major cancer protein amplifies global gene expression</title>
   	 <description>Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A study carried out by researchers at the National Institutes of Health and colleagues found that, unlike many other cell growth regulators, MYC does not turn genes on or off, but instead boosts the expression of genes that are already turned on.</description>
	  <link>http://medicalxpress.com/news/2012-09-major-cancer-protein-amplifies-global.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 27 Sep 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news267965344</guid>
	 
</item>
<item>
     <title>Stem cell therapy for spinal cord injury</title>
   	 <description>Stem cells are considered promising agents for the recovery of spinal cord injuries. European scientists explore their abilities and plan future therapeutic strategies.</description>
	  <link>http://medicalxpress.com/news/2012-09-stem-cell-therapy-spinal-cord.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 25 Sep 2012 09:00:01 EST</pubDate>
	 <guid isPermaLink="false">news267781317</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/stemcellther.jpg" width="90" height="86" />
</item>
<item>
     <title>Researchers seek to understand brain's immune response to metastasized cancer</title>
   	 <description> Brain metastases are common secondary complications of other types of cancer, particularly lung, breast and skin cancer. The body's own immune response in the brain is rendered powerless in the fight against these metastases by inflammatory reactions. Researchers at the MedUni Vienna have now, for the first time, precisely characterised the brain's immune response to infiltrating metastases. This could pave the way to the development of new, less aggressive treatment options.</description>
	  <link>http://medicalxpress.com/news/2012-09-brain-immune-response-metastasized-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 25 Sep 2012 08:10:47 EST</pubDate>
	 <guid isPermaLink="false">news267779434</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/33-researcherss.jpg" width="90" height="90" />
</item>
<item>
     <title>Research finds heart remodeling rapidly follows cardiac injury</title>
   	 <description>Cardiac injury leads to significant structural changes in the heart, including enlargement, excess formation of fibrous growth tissue, and abnormalities of the coronary vasculature. While associated factors have been targeted for therapeutic intervention, the results have been conflicting. Most studies have investigated these changes after six days of injury. However, advanced stages of remodeling have already begun by day seven following injury. New research reveals that morphological changes in response to cardiac injury occur rapidly, with implications for the development of therapeutic strategies. The results are published in the October issue of The American Journal of Pathology.</description>
	  <link>http://medicalxpress.com/news/2012-09-heart-remodeling-rapidly-cardiac-injury.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 04 Sep 2012 00:00:01 EST</pubDate>
	 <guid isPermaLink="false">news265893373</guid>
	 
</item>
<item>
     <title>Therapies for spinal cord injury: On the cutting edge of clinical translation</title>
   	 <description>The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online. </description>
	  <link>http://medicalxpress.com/news/2012-08-therapies-spinal-cord-injury-edge.html</link>
	 <category>Surgery</category>
	 <pubDate>Fri, 31 Aug 2012 11:06:44 EST</pubDate>
	 <guid isPermaLink="false">news265629979</guid>
	 
</item>
<item>
     <title>Do it like the immune system: novel antimicrobials</title>
   	 <description>Microbial infections are becoming unbeatable due to progressive mutations that lead to antimicrobial drug resistance. European scientists exploited the characteristics of novel antimicrobial compounds that mimic the dual activities of natural antimicrobial proteins.</description>
	  <link>http://medicalxpress.com/news/2012-08-immune-antimicrobials.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 30 Aug 2012 09:24:29 EST</pubDate>
	 <guid isPermaLink="false">news265537460</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/doitlikethei.jpg" width="90" height="87" />
</item>
<item>
     <title>Low HDL cholesterol ups risk of diabetic nephropathy</title>
   	 <description>(HealthDay) -- High-density lipoprotein cholesterol (HDL-C) is an independent risk factor for the development of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes, according to research published online Aug. 13 in Diabetes Care.</description>
	  <link>http://medicalxpress.com/news/2012-08-hdl-cholesterol-ups-diabetic-nephropathy.html</link>
	 <category>Diabetes</category>
	 <pubDate>Wed, 22 Aug 2012 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news264871069</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/lowhdlcholes.jpg" width="90" height="90" />
</item>
<item>
     <title>New publication examines effect of early drug administration on Alzheimer's animal model</title>
   	 <description>In a study published June 25 in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer's pathology in a mouse model of the disease. The drug, called MW-151, is a selective suppressor of brain inflammation and overproduction of proinflammatory molecules from glial cells. The drug can be taken by mouth and readily enters the brain. The new study tested the hypothesis that intervention with drugs like MW-151 could be effective as a preventive measure, when administered at an early stage before Alzheimer's pathology appears, as well as after disease symptoms have begun to appear.</description>
	  <link>http://medicalxpress.com/news/2012-07-effect-early-drug-administration-alzheimer.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Tue, 24 Jul 2012 17:10:42 EST</pubDate>
	 <guid isPermaLink="false">news262368632</guid>
	 
</item>
<item>
     <title>Exploring the relation between stem cells and tumor growth</title>
   	 <description>An EU research project has shed light on the tumor-growth role of a key-signalling pathway in mammary gland stem cells.</description>
	  <link>http://medicalxpress.com/news/2012-07-exploring-stem-cells-tumor-growth.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 16 Jul 2012 10:16:34 EST</pubDate>
	 <guid isPermaLink="false">news261652586</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/exploringthe.jpg" width="90" height="90" />
</item>
<item>
     <title>Have no fear: Most cases of thyroid cancer do not affect survival</title>
   	 <description>Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached the most advanced stages of disease. Survival did not vary based on age, sex, or even if patients' cancer had reached the beginning of stage IV.</description>
	  <link>http://medicalxpress.com/news/2012-06-cases-thyroid-cancer-affect-survival.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 11 Jun 2012 14:00:05 EST</pubDate>
	 <guid isPermaLink="false">news258639803</guid>
	 
</item>
<item>
     <title>Marked for destruction: Newly developed compound triggers cancer cell death</title>
   	 <description>The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis. Cells are pressured toward apoptosis by expression of pro-apoptotic BCL-2 proteins. However, cancer cells respond to therapy by increasing expression of anti-apoptotic proteins, which bind and neutralize pro-apoptotic family members and mediate therapeutic resistance. Therefore, development of therapeutic strategies to neutralize resistance to apoptosis will be critical to clinical improvements.</description>
	  <link>http://medicalxpress.com/news/2012-05-destruction-newly-compound-triggers-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 24 May 2012 12:01:24 EST</pubDate>
	 <guid isPermaLink="false">news257077876</guid>
	 
</item>
<item>
     <title>Clinical trials often fall short</title>
   	 <description>Clinical studies registered in clinicaltrials.gov between 2007-2010 are dominated by small, single-center trials and contain significant heterogeneity (different in nature, difficult to compare) in methodological approaches, including the use of randomization, blinding, and data monitoring committees, according to a study in the May 2 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2012-05-clinical-trials-fall-short.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 01 May 2012 16:28:41 EST</pubDate>
	 <guid isPermaLink="false">news255108475</guid>
	 
</item>


</channel>
</rss>
